Skip to content

Categories: omnio

Omnio's Research engineer Assar Bäckman makes his last day at work today. Assar has been an indispensable part of both Omnio and Umeå Biotech Incubator for the last 20 years.

Assar Bäckman hangs up his lab coat and looks forward to retirement

He has been a vital part of Umeå Biotech Incubator (UBI) since its inception in 2003. But now, after 42 years of service in the biotech industry, it is time for respected research engineer Assar Bäckman to retire. “My work has been hugely varied, and over the years I have learned a great deal. I usually have an emergency solution to most things if needed”, says Assar.

Ulrika Norin is the CEO of Umeå based Omnio AB and Tomas Eriksson is the new Chairman of the Board. This week Omnio gives a presentation on its treatment method at the European Wound Management Association annual meeting in Milan, Italy.

New international board promises to take Omnio to the next level

Umeå-based biopharmaceutical company Omnio AB, which is currently awaiting efficacy data from preclinical wound studies using recombinant plasminogen, has recently appointed an internationally experienced board of directors charged with taking the company forward.

Ulrika Norin, CEO Omnio.

Omnio AB raises 5.5 MSEK in fundraising round

Omnio AB is developing new drug products based on the pro-inflammatory and immune regulatory effects of the serum protein plasminogen. During fall the company successfully raised 5.5 MSEK in a new share issue and welcomed four new investors to the company. The added investments make it possible for the company to now initiate its planned activities to develop recombinant plasminogen for treatment

Ulrika Norin, CEO Omnio.

Umeå wound healing company appoints new CEO

Omnio is primarily developing new treatment methods for chronic wounds. These methods are based on research conducted by Professor Tor Ny's group at Umeå University. Ulrika Norin, who recently took up her new position as CEO of Omnio in Marcha while back, has previously worked with various startups in the field of immuno-oncology, where she managed several development projects.

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden